Skip to search formSkip to main contentSkip to account menu

KR 31378

Known as: KR-31378, KR31378 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
KR-31378 is a newly developed K(ATP)-channel opener. To investigate the ability of KR-31378 to protect retinal ganglion cells… 
2005
2005
In this study, we investigated whether a novel anti-ischemic KATP opener KR-31378 [(2S,3S,4R)-N”-cyano-N-(6-amino-3,4-dihydro-3… 
2004
2004
The recruitment of monocytes into the artery wall is a crucial early step in atherogenesis. A novel compound, KR‐31378, has been… 
2004
2004
The opening of the adenosine triphosphate (ATP)-sensitive potassium (KATP) channel has been proposed as a therapeutic approach… 
2004
2004
Dose-dependent pharmacokinetic parameters of KR-31378, a new neuroprotective agent for ischaemia-reperfusion damage, were… 
2003
2003
KR-31378 is a new drug candidate intended for the use in the prevention of ischemia-reperfusion damage. The objective of this… 
2001
2001
The cardioprotective and hemodynamic effects of KR‐31378, a highly cardioselective ATP‐sensitive potassium channel activator with… 
2000
2000
The dose-dependent pharmacokinetic parameters of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378, were…